SLPOtherInternational journal of audiology2019

Sodium salicylate alters temporal integration measured through increasing stimulus presentation rates.

Nicole J Wood, Andrea S Lowe, Joseph P Walton

PMID 30845859

WHAT IT FOUND

In mice, sodium salicylate raised hearing thresholds but made faster stimulus rates improve them.

This altered auditory brainstem response pattern suggests central hyperactivity, not peripheral repair, offering a potential objective marker for tinnitus mechanisms.

Key findings

01Sodium salicylate administration caused a 20–25 dB threshold shift at the lowest stimulus rate, consistent with induced hearing loss.

02Following sodium salicylate treatment, increasing the stimulus presentation rate systematically decreased (improved) ABR thresholds for 12, 16, 24, and 32 kHz frequencies.

03The effect of rate on amplitude was greater in the midbrain (P4) than in the auditory nerve (P1), indicating a central rather than peripheral disruption.

STILL TO COME

How it was doneWhat they foundWhat it means for SLPs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The study was conducted in mice, so findings cannot be directly generalized to human auditory processing or tinnitus. Sodium salicylate is a chemical model of tinnitus that does not replicate the chronicity or psychological impact of human tinnitus. The study did not measure behavioral manifestations of tinnitus, relying on physiological ABR changes as proxies. Data for 32 kHz post-treatment were insufficient for some amplitude analyses due to poor waveform morphology.

Declared interests

The authors declared no actual or perceived conflicts of interest with regards to funding source agencies, NIH or others.

The easy way to misread this

Do not interpret the improved thresholds at higher stimulus rates as a sign of recovered hearing. This phenomenon occurs only after sodium salicylate induces hyperactivity in the central auditory system, representing a specific pathological change rather than a therapeutic benefit.

Read it on PubMed →